drugset / Trial / NCT01724931

Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis

NCT01724931 ↗

Phase 2 Completed 175 enrolled Syntrix Biosystems, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether aminopterin is effective in the treatment of rheumatoid arthritis (RA).

Timeline

Start
2013-02
Primary completion
2014-09
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LD-aminopterin Unknown 1 mg Oral
Subject LD-aminopterin Unknown 3 mg Oral

Indications